PROMUS Element Stent
Email this video to your friends
This video has been added to your favorites.
Video Details
Comments
(0)
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent System, the Company’s third-generation drug-eluting stent (DES) technology. The PROMUS Element system incorporates a unique platinum chromium alloy with an innovative stent design and an advanced catheter delivery system.To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bostonscientific/36501/
Share And Linking
Copy and paste this link into an email or instant message
Copy and paste this code to embed this video into your website or blog
Who's Linking
There are currently no sites linking to this video. Copy the code below and be the first site to link or embed the video!
Top Sites Linking To This Video:
Top Rated Comments
There are no rated comments for this video. Rate a comment now.
